| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $138.9M | -19.1% |
| R&D Expense | $10.4M | -41.6% |
| SG&A Expense | $24.7M | -14.4% |
| Operating Income | -$5.7M | +68.5% |
| Interest Expense | $3K | -94.6% |
| Pre-tax Income | -$3.4M | +65.8% |
| Income Tax | $546K | +605.6% |
| Net Income | $24.1M | +346.9% |
| EPS (Basic) | $1.29 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $21.1M | +85.1% |
| Short-term Investments | $55.7M | +323.5% |
| Accounts Receivable | $27.4M | -18.5% |
| Inventory | $22.7M | -7.8% |
| Current Assets | $131.2M | +49.4% |
| Total Assets | $200.5M | +18.8% |
| Current Liabilities | $38.9M | +14.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $8.9M | +205.7% |
| Capital Expenditures | $14.4M | -23.2% |
| Investing Cash Flow | $375K | +105.6% |
| Financing Cash Flow | $708K | -73.2% |
| Free Cash Flow | -$5.5M | +65.3% |
| +338.9% |
| EPS (Diluted) | $1.29 | +338.9% |
| Total Liabilities |
| $43.9M |
| +10.2% |
| Stockholders' Equity | $156.7M | +21.5% |